FXR AGONISTS FOR HEPATOPROTECTION AND TREATMENT OF CHOLESTASIS

摘要

Methods for the treatment of cholestatic liver disease and reduction and prevention of hepatic injury resulting from cholestasis via administration of a FXR ligand are provided.